Wound Care Market - Historic Data (2019-2024), Global Trends 2025, Growth Forecasts 2037
Wound Care Market in 2025 is assessed at USD 27.67 billion. The global Market size was worth over USD 25.91 billion in 2024 and is poised to grow at a CAGR of around 8.5%, reaching USD 74.83 billion revenue by 2037. North America is on pace to collect USD 26.19 billion by 2037, attributed to robust medical infrastructure and increasing surgical procedures.
The industry growth is mainly credited to an increasing number of slow-healing diseases such as anemia, cancer, and diabetes around the world. Autoimmune diseases such as chronic diseases and lifestyle-related diseases can cause stubborn wounds and injuries that do not heal. For instance, anemia is a condition in which the body cannot produce enough healthy red blood cells. This can slow wound healing because red blood cells are responsible for carrying oxygen throughout the body, and a lack of oxygen can impair the healing process.
Wound care includes the treatment of chronic or complex wounds with products not available without a prescription. Wound care techniques can be categorized into general wound care and advanced wound care. Advanced wound care is a type of wound care that treats complex wounds with less available drugs than basic wound care, which treats simple wounds with readily available drugs. To receive advanced wound care, patients typically need to be treated at a doctor or hospital with an advanced wound care clinic. Wound healing methods include hydrocolloids, hydrogels, and duodenal plasters. These are the plasters that are estimated to have a positive impact on the growth of the global wound care market. It has been observed that 97% of people worldwide prefer using hydrocolloid dressings to conventional daily dressings because of their comfort, intrinsic healing properties, and lack of infection.
Wound Care Sector: Growth Drivers and Challenges
Growth Drivers
- Rising Incidence of Chronic Wounds: Chronic wounds such as diabetic foot ulcers and pressure ulcers are becoming increasingly common, driving demand for wound care products. According to the World Health Organization (WHO), an estimated 422 million people worldwide have diabetes, with around 20% of them developing diabetic foot ulcers. Additionally, the prevalence of pressure ulcers is estimated to be between 10% and 18% in hospital settings.
- Increasing Geriatric Population: The aging population is more prone to developing chronic wounds, hence increasing the demand for wound care products. According to the United Nations, the number of people aged 65 years and older is projected to more than double by the year 2050, reaching 1.5 billion globally.
- Growing Number of Surgeries: As mentioned earlier, surgical wounds require proper care to prevent infection and promote healing. According to a report, around 313 million surgeries are performed each year, with this number projected to increase in the coming years.
Challenges
- High Cost: Advanced wound care products can be expensive, making it difficult for patients to access them. This is particularly problematic in low- and middle-income countries, where patients may not have access to adequate healthcare.
- Lack of reimbursement
- Product development costs
Wound Care Market: Key Insights
| Report Attribute | Details |
|---|---|
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
8.5% |
|
Base Year Market Size (2024) |
USD 25.91 billion |
|
Forecast Year Market Size (2037) |
USD 74.83 billion |
|
Regional Scope |
|
Wound Care Segmentation
Functions (Hospitals, Specialty Clinics, Home Healthcare)
The segment is set to have a substantial market share of 35% in 2037. This can be accredited to the large number of patients requiring advanced wound care and hospitalized for surgery or treatment of chronic conditions such as diabetes and pressure ulcers. The hospital also has the wound care management devices and staff necessary for advanced wound care, including growth factor therapy and negative pressure wound therapy (NPWT).
Applications (Chronic Wounds, Acute Wounds)
In the year 2037, the chronic wounds segment in the wound care market is predicted to command a large proportion of over 60%. The segment's expansion can be attributed to the rising prevalence of chronic wounds such as diabetes, pressure ulcers, and other disorders. In the year 2018, the incidence of chronic ulcers was over 2 per 1000 population and the incidence of chronic leg ulcers was 1 per 1000 population. Chronic wounds can be defined as physiologically compromised wounds resulting from disruption of the wound healing cycle as a result of impaired angiogenesis, innervation, or cell migration, among others. Normal wound healing is discussed separately. Skin wounds that do not heal, heal slowly, or heal but tend to recur are called chronic wounds. Many causes of chronic (permanent) skin wounds may include trauma, burns, skin cancer, infections, or underlying conditions such as diabetes. Wounds that take a long time to heal require special care.
Our in-depth analysis of the global market includes the following segments:
|
Functions |
|
|
Applications |
|
Vishnu Nair
Head - Global Business DevelopmentCustomize this report to your requirements — connect with our consultant for personalized insights and options.
Wound Care Industry- Regional Synopsis
North American Market Forecast
The wound care market in North America region is forecasted to have the most noticeable market share of 35% by the end of 2037. The robust medical infrastructure and increase in surgical procedures in this region are key contributors to regional growth. Therefore, there is an increasing adoption of wound care treatments to prevent postoperative wound infections. The market is also expected to be driven by the increasing incidence of incidents such as road accidents, burns, and trauma, in this region. In addition, increasing disposable income for facial correction and growing people's awareness of wound care equipment are also surging the demand for market in the Asia Pacific region.
APAC Market Statistics
The wound care market in Asia Pacific is expected to have the second biggest share of around 24% by 2037. The continual increase in the region's older population is primarily responsible for the market's growth in this region. The Asia Pacific population is aging faster than anywhere else in the world. Sixty per cent of the world's total elderly population, that is, 630 million people live in the Asia Pacific region. Moreover, the government's role in raising awareness for advanced wound care, increasing the number of wounded patients, and increasing funding for medical infrastructure are expected to spur market growth in the region.
Companies Dominating the Wound Care Landscape
- Arch Therapeutics, Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Convatec Group PLC
- 3M Healthcare
- Convatec Group PLC
- Coloplast A/S
- Cardinal Health
- B. Braun Melsungen AG
- Acelity L.P. Inc.
- Integra Lifesciences Holdings Corporation
- Medtronic plc
Recent Developments
- Arch Therapeutics, Inc. has announced the first shipment of the AC5 Advanced Wound System under a new reimbursement program. AC5 was a synthetic, self-assembling wound care product that enables physicians to provide multimodal support during all stages of the wound healing process.
- Convatec Group PLC has entered into an agreement to acquire Triad Life Sciences Inc. that develops innovative bio-based products that meet the needs of surgical and chronic wounds and burns.
Author Credits: Radhika Pawar
- Report ID: 4823
- Published Date: May 09, 2025
- Report Format: PDF, PPT
